MOH — authorised 23 February 2007
- Marketing authorisation holder: SHIRE DEVELOPMENT
- Status: likely_approved
MOH authorised Vyvanse on 23 February 2007
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 23 February 2007.
SHIRE DEVELOPMENT holds the UAE marketing authorisation.